Objectives: We immunohistochemically analyzed glucose transporter-1 (GLUT-1) expression in endocervical squamous lesions to determine whether GLUT-1 was useful in evaluating cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC) grading.
Study Design: Cytological and histological specimens from 60 cases of CIN—20 each of CIN1, CIN2, and CIN3—and 10 cases of invasive SCC were immunostained using polyclonal GLUT-1 antibody (DAKO, Carpinteria, USA) and simple stain Max (PO) (NICHIREI, Japan). Semiquantitative evaluation was weak (1+), 10%<; moderate (2+), 10-60%; or strong (3+), 60%<.
Results: In normal cervical tissue, weak GLUT-1 staining (8%) was seen in basal squamous epithelial cells. GLUT-1-positive rates were 0% for CIN1, 55% for CIN2, 100% for CIN3, and 100% for invasive squamous cell carcinoma. Koilocytes in the superficial layer were not, however, always labeled with GLUT-1.
Conclusions: GLUT-1 expression is closely associated with CIN progression and is a potential surrogate for CIN evaluation.
View full abstract